Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome

Background Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women. Women with PCOS have androgen excess as a defining feature. They also have increased insulin resistance and obesity, which are also risk factors for non-alcoholic fatty liver disease (NAFLD). However, published da...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Maysara Asfari, Muhammad Talal Sarmini, Firas Baidoun, Yasser Al-Khadra, Srinivasan Dasarathy, Arthur McCullough, Yamen Ezaizi
Format: Article
Language:English
Published: BMJ Publishing Group 2020-12-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/7/1/e000352.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846122328005541888
author Mohammad Maysara Asfari
Muhammad Talal Sarmini
Firas Baidoun
Yasser Al-Khadra
Srinivasan Dasarathy
Arthur McCullough
Yamen Ezaizi
author_facet Mohammad Maysara Asfari
Muhammad Talal Sarmini
Firas Baidoun
Yasser Al-Khadra
Srinivasan Dasarathy
Arthur McCullough
Yamen Ezaizi
author_sort Mohammad Maysara Asfari
collection DOAJ
description Background Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women. Women with PCOS have androgen excess as a defining feature. They also have increased insulin resistance and obesity, which are also risk factors for non-alcoholic fatty liver disease (NAFLD). However, published data regarding PCOS as independent risk factor for NAFLD remain controversial. Therefore, we conducted this study to evaluate the association between PCOS and NAFLD using a large national database.Methods We identified adult female patients (≥18 years) with PCOS using the National Inpatient Sample database between 2002 and 2014. The control group included patients who did not have a diagnosis of PCOS. Multivariate logistic regression analysis was performed to study the association of NAFLD with PCOS.Results Out of a total of 50 785 354 women, 77 415 (0.15%) had PCOS. These patients were younger (32.7 vs 54.8; p<0.001) and more likely to be obese (29.4% vs 8.6%; p<0.001) compared with non-PCOS patients. However, the PCOS group had less hypertension (23.2% vs 39.8%), dyslipidaemia (12% vs 17.8%) and diabetes mellitus (18.1% vs 18.3%) (p<0.001 for all). Using multivariate logistic regression, patients with PCOS had significantly higher rate of NAFLD (OR 4.30, 95% CI 4.11 to 4.50, p<0.001).Conclusion Our study showed that patients with PCOS have four times higher risk of developing NAFLD compared with women without PCOS. Further studies are needed to assess if specific PCOS treatments can affect NAFLD progression.
format Article
id doaj-art-7380afc4b1d5420da23699af4a97a6cf
institution Kabale University
issn 2054-4774
language English
publishDate 2020-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-7380afc4b1d5420da23699af4a97a6cf2024-12-14T17:00:09ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742020-12-017110.1136/bmjgast-2019-000352Association of non-alcoholic fatty liver disease and polycystic ovarian syndromeMohammad Maysara Asfari0Muhammad Talal Sarmini1Firas Baidoun2Yasser Al-Khadra3Srinivasan Dasarathy4Arthur McCullough5Yamen Ezaizi6Gastroenterology and Hepatology, Medical College of Georgia, Augusta University, Augusta, Georgia, USAGastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USAInternal Medicine, Cleveland Clinic, Cleveland, Ohio, USAInternal Medicine, Cleveland Clinic, Cleveland, Ohio, USAGastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USAGastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USAGastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USABackground Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women. Women with PCOS have androgen excess as a defining feature. They also have increased insulin resistance and obesity, which are also risk factors for non-alcoholic fatty liver disease (NAFLD). However, published data regarding PCOS as independent risk factor for NAFLD remain controversial. Therefore, we conducted this study to evaluate the association between PCOS and NAFLD using a large national database.Methods We identified adult female patients (≥18 years) with PCOS using the National Inpatient Sample database between 2002 and 2014. The control group included patients who did not have a diagnosis of PCOS. Multivariate logistic regression analysis was performed to study the association of NAFLD with PCOS.Results Out of a total of 50 785 354 women, 77 415 (0.15%) had PCOS. These patients were younger (32.7 vs 54.8; p<0.001) and more likely to be obese (29.4% vs 8.6%; p<0.001) compared with non-PCOS patients. However, the PCOS group had less hypertension (23.2% vs 39.8%), dyslipidaemia (12% vs 17.8%) and diabetes mellitus (18.1% vs 18.3%) (p<0.001 for all). Using multivariate logistic regression, patients with PCOS had significantly higher rate of NAFLD (OR 4.30, 95% CI 4.11 to 4.50, p<0.001).Conclusion Our study showed that patients with PCOS have four times higher risk of developing NAFLD compared with women without PCOS. Further studies are needed to assess if specific PCOS treatments can affect NAFLD progression.https://bmjopengastro.bmj.com/content/7/1/e000352.full
spellingShingle Mohammad Maysara Asfari
Muhammad Talal Sarmini
Firas Baidoun
Yasser Al-Khadra
Srinivasan Dasarathy
Arthur McCullough
Yamen Ezaizi
Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
BMJ Open Gastroenterology
title Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
title_full Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
title_fullStr Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
title_full_unstemmed Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
title_short Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
title_sort association of non alcoholic fatty liver disease and polycystic ovarian syndrome
url https://bmjopengastro.bmj.com/content/7/1/e000352.full
work_keys_str_mv AT mohammadmaysaraasfari associationofnonalcoholicfattyliverdiseaseandpolycysticovariansyndrome
AT muhammadtalalsarmini associationofnonalcoholicfattyliverdiseaseandpolycysticovariansyndrome
AT firasbaidoun associationofnonalcoholicfattyliverdiseaseandpolycysticovariansyndrome
AT yasseralkhadra associationofnonalcoholicfattyliverdiseaseandpolycysticovariansyndrome
AT srinivasandasarathy associationofnonalcoholicfattyliverdiseaseandpolycysticovariansyndrome
AT arthurmccullough associationofnonalcoholicfattyliverdiseaseandpolycysticovariansyndrome
AT yamenezaizi associationofnonalcoholicfattyliverdiseaseandpolycysticovariansyndrome